Based only on the facts in our directory. The right pick still depends on the job you need done.
Lower starting price
Not comparable
Not comparable: AISAP does not list a price
Free plan
Tie
Neither has one
Higher rating
InHEART
4.1 against 4.2
Same job?
Yes
Both are Healthcare AI tools
Side by side
Compared on
AISAP
InHEART
Our rating
4.1
4.2Better
Starts at
Not listed
Not listed
Free plan
No
No
Category
Healthcare AI
Healthcare AI
Plans
See pricing
See pricing
Key features
Real-time AI interpretation of cardiac ultrasound images at the bedside
FDA clearance in the CADx pathway for structural heart disease diagnosis via POCUS
Structured, auto-generated reporting that cuts documentation time
Works with existing ultrasound hardware rather than a proprietary probe
Integrates with PACS and EMR systems already in place
AI segmentation of CT and MRI scans into interactive 3D heart models
24-hour turnaround from scan submission to delivered model
FDA 510(k)-cleared AI software for cardiac image segmentation
Ablation-strategy planning tools for electrophysiologists
Risk screening for heart failure, sudden cardiac death, and cardio-embolic stroke
Pros
FDA clearance gives it regulatory standing competitors without clearance lack
Hardware-agnostic approach avoids locking hospitals into new ultrasound equipment
Backed by practicing cardiologists as co-founders, not only engineers
FDA 510(k) clearance gives the AI segmentation regulatory credibility beyond a research tool
Founding team combines AI/cardiac-modeling and practicing-physician expertise directly
$15.2M in funding, including an $11M Series A, supports continued clinical development
Cons
Pricing is entirely custom and undisclosed, making budget comparison hard upfront
Aimed at institutions rather than individual clinicians shopping for a personal tool
Regulatory clearance is specific to cardiac and structural heart disease, not general ultrasound reading
No public pricing; adoption requires a hospital procurement and contracting process
Narrow clinical focus (cardiac ablation and risk screening) versus broader cardiology AI suites
24-hour model turnaround may not fit urgent or same-day procedural planning
Company
AISAP, founded 2021
inHEART, founded 2017
Prices come from each vendor's pricing page, last checked 20260730. Check the vendor before you buy.
FAQ
Questions people ask
Is AISAP better than InHEART?
In our reviews AISAP scores 4.1 and InHEART scores 4.2. The better pick depends on the job. AISAP: An FDA-cleared AI platform that reads cardiac ultrasound images at the bedside in real time. InHEART: InHEART builds AI-generated 3D digital twins of the heart to plan cardiac ablation and predict cardiac risk.